Guanylate-binding protein 6 is a novel biomarker for tumorigenesis and prognosis in tongue squamous cell carcinoma

ConclusionThe low expression of GBP6 was associated with tumorigenesis and poor prognosis in OSCC patients, especially in TSCC patients.Clinical relevanceGBP6 may serve as a novel favorable diagnostic and prognostic biomarker in TSCC patients.

http://link.springer.com/10.1007/s00784-019-03129-y

Source: Clinical Oral Investigations - July 13, 2020 Category: Dentistry Source Type: research